Is Aspirin (Acetylsalicylic Acid) indicated for patients with a history of post-pregnancy preeclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Low-Dose Aspirin for Prevention of Preeclampsia in Patients with History of Post-Pregnancy Preeclampsia

Low-dose aspirin is strongly recommended for patients with a history of preeclampsia, including those with post-pregnancy preeclampsia, to prevent recurrence in subsequent pregnancies. 1, 2

Indications for Aspirin Prophylaxis

  • Low-dose aspirin is indicated for women with a history of preeclampsia, especially those with early-onset preeclampsia with delivery before 34 weeks of gestation 3, 4
  • History of preeclampsia is considered a high-risk factor that warrants prophylactic aspirin therapy in subsequent pregnancies 5, 1
  • Women with both chronic hypertension and history of preeclampsia have a significantly higher risk of developing superimposed preeclampsia in subsequent pregnancies (45.7% vs. 30.1% in those with chronic hypertension alone) 5

Dosage and Timing Recommendations

  • The recommended dose is 81 mg/day for most high-risk women 2, 4
  • For women with diabetes or higher BMI (>40 kg/m²), a higher dose of 100-150 mg/day may be more effective 1, 6
  • Aspirin should be initiated between 12 and 16 weeks of gestation (optimally before 16 weeks) and continued daily until delivery 3, 4
  • Starting treatment before 16 weeks of gestation provides greater reduction in preeclampsia risk compared to later initiation 7, 6

Clinical Benefits

  • Low-dose aspirin reduces the risk of preeclampsia by 24% in high-risk women 2
  • The number needed to treat to prevent one case of preeclampsia is 42 in women at increased risk 2
  • Additional benefits include:
    • 14% reduction in risk of preterm birth 2
    • 20% reduction in risk of intrauterine growth restriction 2
    • Increase in mean birthweight by approximately 130g 2

Safety Profile

  • Low-dose aspirin during pregnancy is considered safe with a low likelihood of serious maternal or fetal complications 3, 4
  • No increased risk of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or perinatal mortality 2
  • No significant differences in cesarean delivery rates between aspirin and placebo groups 2

Important Clinical Considerations

  • Aspirin appears most effective for preventing preterm preeclampsia rather than term preeclampsia 6
  • Patient compliance and weight are important variables affecting treatment success 6
  • Despite aspirin therapy, some women still develop preeclampsia, possibly due to mechanisms not affected by aspirin 6
  • The effectiveness of aspirin may be limited in patients with chronic hypertension, kidney disease, or diabetes mellitus as the sole risk factor 7

Guideline Recommendations

  • The American College of Obstetricians and Gynecologists recommends low-dose aspirin for women with a history of preeclampsia, especially early-onset preeclampsia 3, 4
  • The U.S. Preventive Services Task Force recommends low-dose aspirin for women at high risk of preeclampsia, including those with a history of preeclampsia 5
  • The World Health Organization recommends low-dose aspirin (75 mg/day) for high-risk women, including those with a history of preeclampsia 5
  • The American Heart Association and American Stroke Association recommend low-dose aspirin for women with previous pregnancy-related hypertension 5

References

Guideline

Aspirin Prophylaxis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preeclampsia Prevention with Low-Dose Aspirin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Prevention of pre-eclampsia by low-dose acetylsalicylic acid--a critical appraisal].

Zeitschrift fur Geburtshilfe und Neonatologie, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.